Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Dimension in Modeling Irritable Bowel Syndrome (IBS) to Elucidate Novel Diagnostic Biomarkers and Microbiome Signatures

NCT02419963 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02419963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02419963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Dimension in Modeling Irritable Bowel Syndrome (IBS) to Elucidate Novel Diagnostic Biomarkers and Microbiome Signatures
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
December 12, 2016
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhoea predominant irritable bowel syndrome, ibs